A phase I trial of nab-paclitaxel/bevacizumab (AB160) nano-immunoconjugate therapy for metastatic gynecological malignancies: MC1371 (NCT02020707). This is an ASCO ...
Switzerland-based UBS Group AG (UBSG:SW), a multinational investment bank and financial services company co-headquartered in Basel and Zürich and Basel with nearly $1 trillion in total assets, has ...
LONDON, Aug. 27, 2021 — Brytlyt announces they have been granted a patent by the United States Patent and Trademark Office for their ground-breaking algorithm that allows efficient and effective ...
This approach offers an excellent negative predictive value.1 However, its specificity is poor and there is an increasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback